{
  "abstract": "A 51-year-old female patient was diagnosed with primary biliary cholangitis (PBC) in 2012 and rheumafactor-positive, Anti-citrullinated protein antibodies (ACPA)-positive rheumatoid arthritis (RA) in 2013. The diagnosis of a PBC was confirmed by liver biopsy showing portal inflammatory infiltrates with non-suppurative inflammatory lesions of the biliary duct ( figure 1). PBC has been treated with ursodeoxycholic acid since 2012.",
  "authors": [
    {
      "affiliations": [
        "Division of Rheumatology, Immunology and Rehabilitation, Kantonsspital Sankt Gallen, Sankt Gallen, Switzerland"
      ],
      "name": "Florian Popp"
    },
    {
      "affiliations": [
        "Division of Gastroenterology and Hepatology, Kantonsspital Sankt Gallen, Sankt Gallen, Switzerland"
      ],
      "name": "David Semela"
    },
    {
      "affiliations": [
        "Division of Rheumatology, Immunology and Rehabilitation, Kantonsspital Sankt Gallen, Sankt Gallen, Switzerland"
      ],
      "name": "Johannes von Kempis"
    },
    {
      "affiliations": [
        "Division of Rheumatology, Immunology and Rehabilitation, Kantonsspital Sankt Gallen, Sankt Gallen, Switzerland"
      ],
      "name": "Ruediger B Mueller"
    }
  ],
  "title": "Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept",
  "uid": "5b801987-1b09-53ca-862e-8a51174df78f"
}